| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Zenas BioPharma, Inc. | Director | Common Stock | 775K | $13.2M | $17.00 | Sep 16, 2024 | Indirect |
| Jazz Pharmaceuticals plc | Director | Ordinary Shares | 24.7K | $2.75M | $111.35 | Aug 2, 2024 | Direct |
| BioAge Labs, Inc. | Director | Common Stock | 1.71M | Sep 27, 2024 | Longitude Venture Partners IV, L.P. | ||
| Aptinyx Inc. | Director | Stock Option (Right to Buy) | 40K | May 26, 2022 | Direct | ||
| Zenas BioPharma, Inc. | Director | Stock Option (Right to Buy) | 37K | Sep 12, 2024 | Direct | ||
| BioAge Labs, Inc. | Director | Stock Option (Right to Buy) | 15K | Sep 25, 2024 | Direct | ||
| Vera Therapeutics, Inc. | Director | Stock Option (right to buy) | 14K | May 15, 2024 | Direct | ||
| BioAge Labs, Inc. | Director | Series D Preferred Stock | 0 | Sep 27, 2024 | Longitude Venture Partners IV, L.P. | ||
| Zenas BioPharma, Inc. | Director | Series B Convertible Preferred Stock | 0 | Sep 16, 2024 | Indirect | ||
| Zenas BioPharma, Inc. | Director | Series C Convertible Preferred Stock | 0 | Sep 16, 2024 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BIOA | BioAge Labs, Inc. | Sep 25, 2024 | 4 | $7.2M | 4 | Sep 27, 2024 | Director |
| BIOA | BioAge Labs, Inc. | Sep 25, 2024 | 0 | $0 | 3 | Sep 25, 2024 | Director |
| ZBIO | Zenas BioPharma, Inc. | Sep 12, 2024 | 8 | $7.48M | 4 | Sep 16, 2024 | Director |
| ZBIO | Zenas BioPharma, Inc. | Sep 12, 2024 | 0 | $0 | 3 | Sep 12, 2024 | Director |
| JAZZ | Jazz Pharmaceuticals plc | Aug 2, 2024 | 1 | $0 | 4 | Aug 6, 2024 | Director |
| VERA | Vera Therapeutics, Inc. | May 15, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
| JAZZ | Jazz Pharmaceuticals plc | Aug 11, 2023 | 2 | -$171K | 4 | Aug 15, 2023 | Director |
| VERA | Vera Therapeutics, Inc. | May 10, 2023 | 1 | $0 | 4 | May 12, 2023 | Director, 10%+ Owner |
| VERA | Vera Therapeutics, Inc. | Feb 6, 2023 | 1 | $12M | 4 | Feb 8, 2023 | Director, 10%+ Owner |
| JAZZ | Jazz Pharmaceuticals plc | Nov 22, 2022 | 3 | -$1.05M | 4 | Nov 25, 2022 | Director |
| JAZZ | Jazz Pharmaceuticals plc | Aug 5, 2022 | 2 | -$166K | 4 | Aug 9, 2022 | Director |
| APTX | Aptinyx Inc. | May 26, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |
| VERA | Vera Therapeutics, Inc. | May 24, 2022 | 1 | $0 | 4 | May 26, 2022 | Director, 10%+ Owner |
| VERA | Vera Therapeutics, Inc. | Feb 10, 2022 | 1 | $5M | 4 | Apr 5, 2022 | Director, 10%+ Owner |
| JAZZ | Jazz Pharmaceuticals plc | Aug 18, 2021 | 1 | $276K | 4 | Aug 20, 2021 | Director |
| JAZZ | Jazz Pharmaceuticals plc | Jul 29, 2021 | 1 | $0 | 4 | Aug 2, 2021 | Director |
| APTX | Aptinyx Inc. | May 27, 2021 | 1 | $0 | 4 | Jun 1, 2021 | Director |
| VERA | Vera Therapeutics, Inc. | May 18, 2021 | 3 | $10M | 4 | May 18, 2021 | Director, 10%+ Owner |
| VERA | Vera Therapeutics, Inc. | May 13, 2021 | 1 | $0 | 4 | May 17, 2021 | Director, 10%+ Owner |
| VERA | Vera Therapeutics, Inc. | May 13, 2021 | 0 | $0 | 3 | May 13, 2021 | Director, 10%+ Owner |